Biohub have launched a new AI-powered biology initiative, aiming to accelerate scientific discovery and drug development.

The trial of Kenny Alexander, ex-CEO of GVC Holdings prior to its transition to Entain, has been scheduled for early 2028.

Microsoft is continuing its efforts to transform Aspire into a platform for streamlining development and deployment of cloud ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Lidl GB has recalled a batch of roasted cashew nuts due to possible glass contamination, warning consumers of a potential ...

Code Studio is an AI-powered IDE that offers capabilities like autocompletion, code generation and explanations, refactoring ...

The FSA responds to expert criticism of its nitrites in processed meat review, saying the findings reflect current scientific ...

Whilst Genius Sports finished on a strong footing in Q3, it did not go without some financial drawbacks to deal with by the ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

A newly developed peptide, WRPRFa, is giving scientists a clearer view of how the acid-sensing ion channel (ASIC3) drives ...